INDUCTOS

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Lithuania, Poland, Spain, UK.

Active ingredients

The drug INDUCTOS contains one active pharmaceutical ingredient (API):

1	Dibotermin alfa UNII T472P45MG6 - DIBOTERMIN ALFA
	Dibotermin alfa is an osteoinductive protein that results in the induction of new bone tissue at the site of implantation. Dibotermin alfa binds to receptors on the surface of mesenchymal cells and causes cells to differentiate into cartilage- and bone-forming cells. The differentiated cells form trabecular bone as the matrix is degraded, with vascular invasion evident at the same time.
	Read more about Dibotermin alfa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
INDUCTOS Powder, solvent and matrix for implantation matrix	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M05BC01	Dibotermin alfa	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BC Bone morphogenetic proteins
Discover more medicines within M05BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1212376, 1703360
ES	Centro de información online de medicamentos de la AEMPS	02226001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	181720
FR	Base de données publique des médicaments	60897889
GB	Medicines & Healthcare Products Regulatory Agency	385296, 89931
IT	Agenzia del Farmaco	035913019
LT	Valstybinė vaistų kontrolės tarnyba	1028450, 1078251
PL	Rejestru Produktów Leczniczych	100219451